Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cellgram ED
- Development stage
- Phase 2
- Lead developer
- Pharmicell
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intracavernous, Intracoronary
01
Overview
Cellgram ED is an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy developed by Pharmicell for the treatment of erectile dysfunction (ED). It is specifically designed for patients who are non-responsive to conventional phosphodiesterase type 5 (PDE5) inhibitors. The therapy involves the extraction of a patient's own bone marrow, from which MSCs are isolated, cultured, and subsequently injected into the corpus cavernosum of the penis. The mechanism of action relies on the regenerative potential of MSCs, which exert paracrine effects by secreting various growth factors that promote the repair of damaged cavernous nerves and vascular endothelial cells. This regenerative process aims to restore natural erectile function in patients with severe ED. The drug is currently undergoing clinical evaluation in South Korea.
- Brand names
- Cellgram ED
- Other names
- Cellgram-ED
Beyond the preview
Go deeper on Cellgram ED.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cellgram ED.